首页> 外文期刊>Clinical lung cancer >Clinicopathological features in young patients treated for small-cell lung cancer: Significance of immunohistological and molecular analyses
【24h】

Clinicopathological features in young patients treated for small-cell lung cancer: Significance of immunohistological and molecular analyses

机译:小细胞肺癌治疗的年轻患者的临床病理特征:免疫组织学和分子分析的重要性

获取原文
获取原文并翻译 | 示例
       

摘要

Background Small-cell lung cancer in young patients is very rare and has not been adequately described. In addition, malignancies associated with genetic rearrangements of nuclear protein of the testis (NUT) have been reported in young patients. Patients and Methods We reviewed the clinical records of patients younger than 40 years of age who had been diagnosed as having SCLC and had been treated for this condition. We also examined NUT rearrangements using immunohistochemistry (IHC) staining and fluorescence in situ hybridization (FISH) analysis. Results We evaluated the diagnoses and treatment outcomes of 8 young patients among 747 SCLC patients. Based on further analyses using IHC staining and FISH, NUT rearrangements were found in 2 of these cases. The range of the overall survival period was 3.6 to 49.7 months. The 2 patients with NUT rearrangements survived for less than 12 months. Conclusion NUT rearrangements were identified in 2 patients who had been previously diagnosed as having SCLC. Further attention regarding the diagnosis of SCLC in young patients is needed.
机译:幼小患者的小细胞肺癌非常罕见,尚未得到充分描述。此外,患有睾丸(坚果)的核蛋白质遗传重排相关的恶性肿瘤已经报道,在年轻患者中报道。患者和方法我们审查了40岁的患者的临床记录被诊断为具有SCLC,并被治疗这种情况。我们还使用免疫组织化学(IHC)染色和原位杂交(鱼类)分析的荧光检查螺母重排。结果我们在747例SCLC患者中评估了8名年轻患者的诊断和治疗结果。基于使用IHC染色和鱼类的进一步分析,在其中2例中发现了螺母重排。整体生存期的范围为3.6至49.7个月。 2例螺母重排患者存活不到12个月。结论螺母重排在2例以前被诊断为具有SCLC的2例患者中均确定。需要进一步关注年轻患者SCLC的诊断。

著录项

  • 来源
    《Clinical lung cancer》 |2014年第3期|共4页
  • 作者单位

    Division of Thoracic Oncology National Cancer Center Hospital 5-1-1 Tsukiji Chuo-ku Tokyo 104;

    Division of Thoracic Oncology National Cancer Center Hospital 5-1-1 Tsukiji Chuo-ku Tokyo 104;

    Division of Pathology National Cancer Center Hospital Tokyo Japan;

    Division of Thoracic Oncology National Cancer Center Hospital 5-1-1 Tsukiji Chuo-ku Tokyo 104;

    Division of Thoracic Oncology National Cancer Center Hospital 5-1-1 Tsukiji Chuo-ku Tokyo 104;

    Division of Thoracic Oncology National Cancer Center Hospital 5-1-1 Tsukiji Chuo-ku Tokyo 104;

    Division of Thoracic Oncology National Cancer Center Hospital 5-1-1 Tsukiji Chuo-ku Tokyo 104;

    Shien-Lab National Cancer Center Hospital Tokyo Japan;

    Division of Breast and Medical Oncology National Cancer Center Hospital Tokyo Japan;

    Division of Thoracic Oncology National Cancer Center Hospital 5-1-1 Tsukiji Chuo-ku Tokyo 104;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

    Chemotherapy; FISH; IHC; NUT midline carcinoma; NUT rearrangements;

    机译:化疗;鱼;IHC;螺母中线癌;坚果重排;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号